Cidara CEO Stein brings Trius gang, biotech vets together

Everyone wondering what Jeffrey Stein would do next after Cubist Pharmaceuticals acquired Trius Therapeutics has their answer: The former Trius president and CEO will lead the antifungal startup Cidara Therapeutics and bring colleagues from his prior post and other local companies to the new venture.

More from Anticancer

More from Therapy Areas